Share chart Bone Biologics Corporation
Extended chart
Simple chart
About Bone Biologics Corporation
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. more details| IPO date | 2016-03-31 |
|---|---|
| ISIN | US0980703039 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.bonebiologics.com |
| Цена ао | 0.8273 |
| Change price per day: | 0% (0.83) |
|---|---|
| Change price per week: | +1.57% (0.8172) |
| Change price per month: | -19.42% (1.03) |
| Change price per 3 month: | -26.55% (1.13) |
| Change price per half year: | -52.02% (1.73) |
| Change price per year: | -64.38% (2.33) |
| Change price per 3 year: | -50.6% (1.68) |
| Change price per 5 year: | 0% (0.83) |
| Change price per 10 year: | 0% (0.83) |
| Change price per year to date: | -7.79% (0.9001) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Tower Research Capital LLC (TRC) | 1225 | 0.23 |
| Wells Fargo & Company | 4 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Jeffrey Frelick | CEO & President | 325k | 1966 (59 years) |
| Ms. Deina H. Walsh | Chief Financial Officer | 212.5k | 1964 (61 year) |
Address: United States, Burlington. MA, 2 Burlington Woods Drive - open in Google maps, open in Yandex maps
Website: https://www.bonebiologics.com
Website: https://www.bonebiologics.com
